Publikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (33)

2024

  1. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. AEEH «Consensus about detection and referral of hidden prevalent liver diseases»

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 236-247

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19

    European Journal of Epidemiology, Vol. 38, Núm. 8, pp. 883-889

  5. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  6. Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

    FASEB Journal, Vol. 37, Núm. 11

  7. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  8. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

    Gut, Vol. 72, Núm. 8, pp. 1581-1591

  9. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

    Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737

  10. Training and competence in Digestive Endoscopy: Statement Position Paper from the Spanish Society of Digestive Diseases

    Revista Espanola de Enfermedades Digestivas

2022

  1. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2276-2286.e6

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study

    Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143

2020

  1. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 4, pp. 963-973.e14

  2. Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) (Journal of Hepatology (2020) 73(1) (17–25), (S0168827820301276), (10.1016/j.jhep.2020.02.028))

    Journal of Hepatology

  3. Genomewide association study of severe covid-19 with respiratory failure

    New England Journal of Medicine, Vol. 383, Núm. 16, pp. 1522-1534

  4. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710

  5. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

    Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25

2019

  1. Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis

    Frontiers in Immunology, Vol. 10, Núm. MAR